Abstract:We report the synthesis and evaluation of a series of cell-permeable and N- versus O-selective sialyltransferase inhibitors. Inhibitor design entailed the functionalization of lithocholic acid at C(3) and at the cyclopentane ring side chain. Among the series, FCW34 and FCW66 were shown to inhibit MDA-MB-231 cell migration as effectively as ST3GALIII-gene knockdown did. FCW34 was shown to inhibit tumor growth, reduce angiogenesis, and delay cancer cell metastasis in animal models. Furthermore, FCW34 inhibited vessel development and suppressed angiogenic activity in transgenic zebrafish models. Our results provide clear evidence that FCW34-induced sialyltransferase inhibition reduces cancer cell metastasis by decreasing N-glycan sialylation, thus altering the regulation of talin/integrin/FAK/paxillin and integrin/NFκB signaling pathways.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01477?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01477</a>.Effect of 2aA–2eA on migration in MDA-MB-231 cells; effect of FCW34 on migration in MDA-MB-231 cells; effect of FCW66 on migration in MDA-MB-231 cells; effects of ST3GALIII siRNA knockdown efficiency in MDA-MB-231 cells; inhibition of integrin sialylation by sialyltransferase inhibitors in MDA-MB-231 cells; effects of sialyltransferase inhibitor FCW34 on tumor metastasis in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitor FCW34 on toxicity assessment in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitors on the integrin–FAK–paxillin pathway in MDA-MB-231 cells; effects of sialyltransferase inhibitors on the NFκB pathway in MDA-MB-231 cells; apparent permeability (Papp) values obtained for the reference compounds, FCW34, and FCW66 using the PAMPA model; endogenous expression of ST6GALI, ST3GALIII, ST3GALI, and ST6GALNACI proteins; comparison of binding modes of 2aA–2eA, 3cB–3dB, 4cC–4dC, AL10, LCAG, and Lith-O-ASP in the binding sites of two asymmetric polypeptide chains (A/B) of ST6GALI (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QVT">6QVT</a>); computed physicochemical properties of the selected compounds used in this study; computational binding values of complex structure of ST6GALI-inhibitor; sensitization of tumors to ST inhibitors by regulation of the talin/integrin/FAK/paxillin and integrin/NFκB-signaling pathways; and experimental procedures, details of HPLC-determined purity data, HRMS results, and 1H and 13C NMR spectra of all final compounds and intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Highly Substituted Cyclopentane-Cmp Conjugates As Potent Sialyltransferase Inhibitors

Design, synthesis and evaluation of carbamate-containing sialyltransferase inhibitors

Transition State-Based Sialyltransferase Inhibitors: Mimicking Oxocarbenium Ion by Simple Amide

An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitors

Synthesis of α‐Hydroxy‐1,2,3‐Triazole‐linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

3D-QSAR Analysis of Sialyltransferase Inhibitors

Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis

Ginsenosides, potent inhibitors of sialyltransferase

Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study

Recent Development in the Design of Sialyltransferase Inhibitors

A Rapid and Sensitive MicroPlate Assay (MPSA) Using an Alkyne‐Modified CMP‐Sialic Acid Donor to Evaluate Human Sialyltransferase Specificity

Self-Assembled Core-Shell Nanoscale Coordination Polymer Nanoparticles Carrying a Sialyltransferase Inhibitor for Cancer Metastasis Inhibition

Affinity-Based Covalent Sialyltransferase Probes Enabled by Ligand-Directed Chemistry

Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis

Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities

Design, synthesis and cytotoxic activity of sulfonylated derivatives of camptothecin

Design, Synthesis and Biological Activity Evaluation of Novel Covalent S -Acylation Inhibitors

Design and Synthesis of Novel 7-[(N-substituted-thioureidopiperazinyl)-methyl]-camptothecin Derivatives As Potential Cytotoxic Agents.

Design, Synthesis and Biological Evaluation of Sulfonylamidines As Potent C-Met Inhibitors by Enhancing Hydrophobic Interaction.